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ABSTRACT: 
Automated multiphasic test laboratories have many applications, 
ranging from periodic health examinations to diagnostic survey. 
Such facilities save time for the patient and the doctor, both in the 
administration of the examination and, perhaps, in detecting and 
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Kaiser-permanente experience to date indicates that patient accept-
ance of the program is high. It takes two to three hours for complete 
testing, and then the healthy patient spends about 15 minutes with 
a physician for review and analysis. If the patient is not healthy, 
examination may be much longer. The examination includes a ques-
tionnaire which contains about 600 medical questions. This has been 
shown to be quite reliable and reproducible; it also provides the 
opportunity to perform research to increase the reliability of the 
testing procedures. There is also the potential of administering psy-
chological inventory-type examinations to accomplish the kind of 
subjective judgments a physician often makes during patient inter-
views. The cost of the examination using the multitest laboratory is 
approximately $22, compared to a cost of over $100 if the same 
tests were to be done in the traditional manner. In the Salt Lake 
area, a similar type examination is performed on patients being 
admitted to the hospital; automated equipment is utilized, and com-
puterized analysis is performed. However, the objectives of the 
Salt Lake program are different than those of the Kaiser-Per-
manente program in that the former is dealing with a sick popula-
tion, while the latter is dealing primarily with a well population. 
One of the greatest problems in instituting such a program is to con-
vince the physicians to accept the value of automating procedures 
which have traditionally been quite personal in nature. It requires 
orientation, education, and demonstration to the physicians that 
multiphasic screening will save them time, will improve the quality 
of the exams and will decrease the cost of examinations. Although 
there is incomplete scientific evidence that periodic health examina-
tions are significantly beneficial to the total population, there are 
indications that if adequate research were to be conducted it could 
indicate individual benefits and would probably show an overall 
value, particularly in terms of long-range prediction and prevention. 
Automated testing and examinations will make it easier to gather 
data from which such long-term information might be analyzed. The 
technology is now available to perform automated examinations, to 
maintain quality control upon such examinations, and to collect and 
analyze greater quantities of data from the examinations of greater 
numbers of the population. A side benefit of the automation of exam-
inations is that the training level of technical personnel need not be as 
high as it has in the past; a person holding an M.D. or Ph.D. is not 
required at all levels of the testing process. This may help alleviate 
the critical problem of a doctor shortage in the nation. The require-
ments for a successful multitest laboratory operation include high 
volume (approximately 2,000 patients per month), support of local 
physicians, high-quality service, and reasonable price rates. The 
minimum level in terms of population is probably about 200,000. 
A community considering multitest facilities should be at least that 
large. It is probably better to have patients from outlying areas come 
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to the testing laboratory, rather than to attempt transportation of 
the laboratory to small population areas. The key to continued suc-
cess is quality control, and this is difficult to maintain with mobile-
type laboratories. In the future, multitest laboratories will be locat-
ed in every community of 200,000 or more. The entire population 
will undergo periodic screening on a regular basis, probably based 
on age. These multitest laboratories will be tied together through 
some kind of computer network so that data gathering and informa-
tion exchange will be facilitated. With the availability of vast quanti-
ties of information covering the entire population, it will likely be 
possible to diagnose disorders prior to the appearance of what are 
today. . called "symptoms" through careful analysis of such . subtle 
variables as body chemistry, physiological disturbances, stress re-
sponse and so on. 
THE DISCUSSION: 
CASTLE : If multiphasic screening and periodic health examinations 
can detect earlier those persons who have significant disease, can we 
alter the national course of disease and thereby decrease costs of 
care? Also, if we're going to provide many more periodk health 
examinations, how many doctors will we need? How can we im-
prove the efficiency of physicians' multiphasic screening within the 
concept of the periodic health examination? Does it significantly 
save physician time, permitting doctors to provide more periodic 
health examinations in a shorter time at a more reasonable cost? 
Even if you don't believe in periodic health exams, it seems to me 
automating some of the things we do would still be justified. 
CoLLEN: Automated multitest laboratories have many objeetives, 
of which periodic health examinations are only one. The automated 
multitest lab can be used for examinations of patients whom the 
physician may refer to the laboratory for a diagnostic survey. 
Similarly, patients who are ambulatory and going into a hospital 
can receive a battery of tests through such a multitest laboratory, 
which will provide an admission profile of information which saves 
the patient time, saves the doctor time, saves costs, and may in some 
instances initiate treatment earlier, thereby decreasing length of 
hospital stay. Industrial exams, pre-employment exams, executive 
exams - there are many purposes for which such a multitest labora-
tory can be used in addition to just the periodic health exams. 
CASTLE: If a patient comes in with symptoms, do you think the multi-
test laboratory facilitates the physician making the diagnosis, or do 
you think the physician does a better job in seeing the patient, taking 
the symptom, and then identifying the specific test he needs and 
just getting that one? 
CoLLEN : These are the two alternatives, of course. Since the great 
majority of people have some symptoms, we assume that every 
.. 
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patient has some abnormality and the objective is to identify import-
ant clinical conditions which cause those symptoms. It has been our 
experience that the great majority of patients save time by being 
able to obtain a whole battery of tests within two to three hours 
which ordinarily would take a whole day. It is also our experi-
ence that 70 to 90 percent of patients can be taken care of by one 
single visit to the doctor. Those who have important clinical abnor-
malities can then be followed up in a more traditional manner, but 
those who are generally healthy can be fully taken care of in one 20-
minute visit with the physician. 
CASTLE: It seems sort of cold and inhuman to have the patient go 
to a laboratory first. His first encounter with the health system is 
through a laboratory. 
NoEHREN : Yes, and if they're essentially healthy, why do they have to 
see a doctor at all? Why not just leave the blood sample, and we'll 
let you know whether we need to see you any further? 
CoLLEN : Our experience is that patient acceptability of the program 
is generally very high. I think the majority of patients clearly 
separate in their minds a laboratory from a doctor's office, so that 
going to the laboratory, whether it is first or after, is not material 
to the patient, but going through a complete, modern, highly-tech-
nical laboratory is very impressive to them. As far as being willing 
to see the physician if they're healthy, there are many hundreds of 
conditions which we don't attempt to identify because they are very 
rare or because they are very costly, and so if a patient goes through 
the multitest laboratory and has no test abnormalities, it merely 
means that he does not have these specific conditions. He may have 
any of several hundred other conditions which the physician will 
have to attempt to identify in his followup. 
NoEHREN: So if it takes the physician 15 minutes to read the card 
and find out who the patient is, how much else can he do in that 
short period of time? You're talking about just diagnosis; you're 
not talking about treatment. Is that right? 
CoLLEN: It only takes a few minutes for the physician to review the 
summary report which he obtains. The summary report is so struc-
tured that it's easy to follow. Abnormalities are identified with 
asterisks so that it brings to his attention those test results which are 
important. If all the tests are normal on the report, he can deter-
mine this within a few minutes. Then he will need only to follow 
through with the patient the special problems or complaints not in-
cluded. Then he completes his physical examination. He doesn't 
have to ask all the routine questions; they have already been done 
before. All of these routine questions and procedures have been 
pushed forward in time into the laboratory so he can start right in 
with the definitive decision-making process and try to come to a 
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diagnosis. If he confirms that there are no other significant com-
plaints and no other abnormalities found on examination, he can 
then discharge the patient. · If, however, he finds an abnormality, 
then-·he arranges additional exams. 
NoEHREN: That's not figured in this 15 minutes. 
CoLLEN: No. The 15 minutes is just for those who have no important 
abnormalities. 
NoEHREN: By the time you've taken enough histories, it becomes 
rather apparent that you learn a great deal about the patient just in 
the way he answers his questions. It seems to me you're transferring 
this very subjective and very personal feeling for the patient to the 
character of his handwriting. This is rather an abbreviated form of 
typecasting a personality. This is hard to buy. 
CoLLEN: When one deals with automated history tiling and self-
administered questionnaires, the subjective character is, of course, 
eliminated. This is why it is still necessary for the physician to see 
the patient after the exam. That component of data acquisition 
which is objective and can be quantitative we can build . into the 
machine. 
NoEHREN: How many questions do you ask? 
CoLLEN: Well, we ask some 600 medical questions. We have es-
sentially three questionnaire phases. One is the past history that the 
patient answers at home, the second is the interval history that the 
patient answers while he is there; and, the third is the inventory 
by systems, which is 200 of the usual questions every doctor asks. 
NoEHREN: I doubt if we ask 600 questions in the period of an exami-
nation. 
CoLLEN: Of course not. No patient can afford to pay a doctor to 
take the time to ask that many questions. That's why we moved it 
into the multitest laboratory. We have been able to conduct con-
siderable studies evaluating the reliability of such a questionnaire, 
and we've published those. Very few physicians have any idea as 
to the reliability of their questions. 
No EHREN : Their questions or their answers? 
CoLLEN: Both. You never ask the same question the same way; you 
ask them differently, and so the responses are different. In our ques-
tionnaire we have found that the reproducibility of these questions 
can be measured. We know that some questions are very reproduc-
ible and "hard" questions, so to speak. Others are quite unreliable 
questions, and so we continually improve and revise questions to 
increase the reliability. For example, we can assure a physician that 
if the patient response to a question is "no," that if he asks that 
question a second time, better than 98 percent of the second re-
.· 
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sponses will be "no" again. The reproducibility of a "no" response 
is very good. The reproducibility of a "yes" response, however, is 
not so good. They might change their minds because they may not 
be sure or they may want the doctor to ask more about it. 
NoEHREN: That may be obliging the doctor. I think we all suffer 
from that, don't we? 
WARNER: I wouldn't be quite so quick to discard the self-administer-
ed history as not being an important source of information about the 
patient's psychological makeup. At the Mayo Clinic for at least four 
or five years now they have been routinely administering a Minne-
sota multiphasic modified kind of psychological questionnaire which 
is designed to present to the doctor at the time he first sees the 
patient a statement regarding the psychological makeup of that 
patient. This has proven to be a very helpful thing in determining 
which patients need a rather detailed psychiatric workup, so these 
self-administered questionnaires can be a very significant help to the 
doctor in sizing up the psychological makeup of that patient. 
CASTLE : Can I ask you another question? We're talking about multi-
test laboratory and multiphasic screning as though it's one thing, and 
I get the impression that when Homer says multiphasic screening 
he may mean one thing, and when someone else talks about multi-
phasic screening he may mean an entirely different battery of tests. 
When we talk about costs, what is the battery of tests that you use? 
COLLEN: I'll describe briefly the tests that we include. Many of them 
are under evaluation. One must tailor the laboratory and screening 
program to the population being examined, and so every laboratory 
may have different test phases. Our laboratory has a registration 
station first, then electrocardiogram, blood pressure, body measure-
ments, and a series of X-rays. We now do a flat film of the abdomen, 
which is under evaluation. We wouldn't recommend it yet, not until 
we evaluate how useful it is to detect disease. We do a mammo-
graphy in women over 47. We've found that one in every 500 women 
going through our program has cancer of the breast and so we feel 
that's important. Then we do a visual acuity, tonometry for glau-
coma, hearing tests, and respirometry. We have a questionnaire, 
as I described. Then the blood samples are drawn, and we do at 
least eight serum chemistries, serum glucose one hour after 7 5 gram 
challenge dose, cholesterol, uric acid, calcium transaminase, albumin 
and total protein. 
NoEHREN: Wait a minute. The patient's getting weak from loss 
of blood. How much blood do you need? 
CoLLEN : We draw four vacutainer tubes, about 12 to 15 cc. We 
do hematology with the Coulter counter, (hemoglobin, white count, 
red count and indicies) ; VDRL test for syphilis; blood typing; and 
also rheumatoid factor by the latex fixation test. 
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CoLLEN: We estimate that in the usual manner it would be about 
$100 or more. Our cost, by packaging it in the multitest laboratory 
and by examining a group of 100 to 120 per day, providing the 
summary report, all interpretation, amortization of equipment and 
facilities is about $22. 
NoEHREN: Does that include the doctors? 
CoLLEN: This does not include the physicians' followup, but it does 
include the physicians' costs to read the EKG's and X-rays in our 
programs. 
CASTLE: Does it include the physician's initial contact with the 
patient where he has the data? 
CoLLEN: No, it does not. Any patient who goes through the multi-
test laboratory can see any physician in the community, and there-
fore, these costs are not included. Most of them see our doctors 
within our health plan program. 
NoEHREN: Does this include the amortizing of the equipm~nt, too? 
CoLLEN: Yes. Amortizing of equipment, rental of space, plant main-
tenance, indirect costs, overhead- everything. 
NoEHREN: Has Medicare heard about this yet? 
WARNER: This is quite a different battery of tests than we perform-
a much more comprehensive battery in some senses. Our screening 
activities here in the Salt Lake area have been limited to screening 
patients who are already being admitted to the hospital for /some 
known abnormality. Many of these are surgical patients coming in 
to have an operation. We screen them on admission, primarily to 
assess the status of their body independent of the condition for which 
they're being treated. For instance, a patient might be coming in 
for a hernia operation who also has a respiratory problem we'd like 
to know about before he's given a general anesthetic, and so our 
battery of tests is somewhat different. First, the patients have an 
electrocardiogram, which is read directly by the computer. The 
electrocardiogram is classified into either normal or one of several 
families of abnormal patterns, so this isn't a diagnosis but an EKG 
classification. Second, the patient breathes into a spirometer, and 
this is automatically read by the computer. The values then are 
presented back at the bedside as a percent of the expected value for 
that patient's height, weight, age, and sex. They are recorded this 
way into the computer record. Third, a blood sample is drawn and 
the 12-channel standard battery is done on this, as well as the 
routine hematology and urine. The blood pressure and temperature 
are taken by the nurse at the station, so that this is out of the way 
by the time the patient gets to his room. While he's waiting to be 
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admitted to one of the examining rooms, he starts taking a history 
questionnaire which is presented to him in the form of a little book 
which has one IBM card in it and a series of pages with questions 
on them. He then simply punches out the hole if his answer to that 
question is "yes." We end up with one card with a series of holes 
in it, which then can be fed through the computer to record his 
answers. 
NoEHREN: Is this a "yes" or "no" questionnaire? He can't pursue 
a "yes" answer. 
WARNER: No. It's just a screening device, and we cover much of 
the same territory Dr. Collen does. 
NoEHREN: How many questions on it? 
WARNER: There are 280 at present. These are questions that have 
been designed by specialists serving on a committee at the hospital. 
Specialists in each of the areas have designed questions for their 
particular area, and we hope in time to do research on the ques-
tions as to reproducibility, effectiveness, and reliability with regard 
to actually separating patients with a particular disease from other 
patients. We have a study going now, for instance, in which the 
patient will take the test by answering the questions directly on the 
punch card, and then when he gets to the ward the resident will 
interview him and ask the same questions. We'll then compare the 
answers this way. This answers one of the questions we'd like to 
know: Do the patients understand the questions? Is it different if 
they're presented by a doctor who can perhaps do some explaining 
if they have difficulties with them? 
NoEHREN: Do you have any answers yet? 
WARNER: We don't. We're just starting that study. 
CoLLEN: We have compared interview questions on forms with ques-
tions on cards, but not using physician interviews. 
CASTLE: I sense from what you said earlier that the package Dr. 
Warner is talking about can provide for a patient who has illness, 
who has symptoms, but that this would not be as large a package 
as you would recommend. 
CoLLEN: It's a different package, and as I emphasized, you tailor 
your own laboratory to your own needs. Dr. Warner is much more 
sophisticated than we are in that we don't have computer analysis 
of the electrocardiogram and spirogram, but he's dealing primarily 
with patients going into a hospital, and we're dealing primarily 
with office patients. As our objectives become more similar to Dr. 
Warner's, then we will probably want to do many of the things he's 
doing. 
NoEHREN: You're dealing with a well population, and he's dealing 
with a sick population. 
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CoLLEN: That's a fair description. 
CASTLE: How do the physicians respond to this? It seems to me this 
is a tremendous change from what they've been taught in medical 
school and in their training. My guess would be that physicians 
wouldn't take very well to having the laboratory do these things in 
an automated way. 
CoLLEN: Physicians are properly skeptical of all innovations until they 
are proven to either improve quality or economy. One must dem-
onstrate that these innovations do have high utility, and until these 
are demonstrated, the physicians often will not accept the programs. 
We have been using multiphasic screening techniques in periodic 
health examinations since 1949, and so the majority of our physi-
cians do accept them. However, there are still some who believe 
periodic health examinations have not yet been proven to be of 
value. They are not very enthusiastic about periodic health examina-
tions and, therefore, are not very enthusiastic about any method of 
doing them, including those which use multiphasic screening tech-
niques. It requires orientation, education, and demonstration to the 
physicians that it will save them time, improve the quality of the 
exams, decrease the cost of the exams, and so. forth. 
NoEHREN: What's your answer to the doctor who doesn't believe 
these routine examinations pay off? Do you have an answer? 
CoLLEN: No. There's no scientific evidence that if one has a periodic 
health exam every year or two that he's going to live any longer or 
that he's going to have fewer hospital days in the future or 1~ dis-
ability. This has not yet been demonstrated, and there are ·those 
who question the long-term value of periodic health exams. Our 
health plan made the decision that it was going to provide periodic 
health examinations to those who joined the program. 
NoEHREN: You are working on faith, then. Is that right? 
CoLLEN: Yes. 
WARNER: I don't quite agree with you on this. It seems to me that 
certain groups, such as the Framingham group and others, have pin-
pointed certain risk factors for heart disease; for instance, they have 
made it very clear that patients who are obese, or patients who have 
smoking habits, or patients who have high cholesterol have addi-
tional risk of illness. We know from other studies that if those factors 
are detected early- those are just a couple of very simple things-
and if the doctor gives his advice, and if the patient follows that 
advice, the risks change. I don't think we need to wait another 20 
years to see that those particular patients survive who happen to be 
detected through a multiphasic screening unit. I think the evidence 
is pretty clear already in certain diseases that these risk factors exist 
and that certain early conditions which represent risk factors are 
reversible. 
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CASTLE: Hypertension is a perfectly good example. We know the 
risks increase with elevated blood pressure. We also know that if you 
change that blood pressure level and bring it back down to normal, 
you can very definitely alter the course of the patient. There are 
several similar examples. If you put them together, it becomes rather 
convincing that if you detect the disease early and treat it effective-
ly, you can do something to alter the course. I think you leave the 
impression that we haven't answered the question in the affirmative, 
when we really haven't looked at the problem long enough to get 
an answer. 
N OEHREN : Isn't some of the skepticism concerned with whether or 
not it's worth the cost? Hasn't this been one of the major stumbling 
blocks in this area? We went through this with routine chest X-rays 
with the public health service, and they found that it cost $25,000 
to pick up a new case of tuberculosis. There was no question about 
picking up the case of tuberculosis, but was it worth $25,000 to 
find that case? 
CoLLEN : Correct. Economists are beginning to ask if cost benefit 
studies have been completed, but it is difficult to do these because 
it does take 10 to 20 years to complete such a cost benefit study. If 
we look at individual conditions, we do believe that decreasing 
weight, decreasing or normalizing blood pressure, decreasing blood 
sugar, and so forth, will help individually. What we're trying to do is 
measure the overall effect on a group of people if we monitor the 
state of health and disease over a period of time. 
N OEHREN: You're interested in the population group, then, aren't 
you? 
CoLLEN: We're trying to measure the effect on a population group. 
This is more difficult, and essentially, this is what the government 
and large groups are interested in. If they invest resources in health 
monitoring or health surveillance of a population, 20 years from now 
will the results be worth it? 
NoEHREN: Don't the insurance companies have some answers on 
this? 
CoLLEN: Many years ago Metropolitan Life Insurance began to do 
a study, but they never finished it, or at least never published any 
results. They began a study to try to measure the effect of health 
examination on longevity. They published the statement of their 
study, but they never followed through. Whether or not they com-
pleted it, I don't know. 
CASTLE: How is it that you had so much foresight to begin some-
thing 20 years ago which only now seems to be in the mind of every-
one else? 
• 
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COLLEN: Well, we started 20 years ago because it was necessary from 
the viewpoint of economics. Dr. Garfield, the founder at our organ-
ization made the decision that we should include periodic health 
exams as one of the benefits available to our subscribers. So we had 
to provide it in an economical and efficient manner, and that's why 
we started. In a way, I see the same question arising nationwide. 
Prominent people are beginning to feel that the people ought to 
have more care, more examinations, and so forth. Therefore, if our 
country is going to make a decision - by Preventicare or other 
legislation - that periodic health exams should be provided to the 
people, then what's the most economical way of doing it? A resurg-
ence of interest in multiphasic screening and multitest laboratories 
is now developing to respond to that need which is apparently deve-
loping. 
WARNER: There's another important factor here that accounts for at 
least part of the resurgence of interest in this screening process, and 
that's the technology itself. Doctors don't particularly like to do 
examinations on healthy people; it's uninteresting. As we learn ways 
of doing this that don't involve doctors and that take some of the 
drudgery out of it, not only is it economically more feasible, but 
from the point of view of the people who have to do it, it's a lot 
more exciting. I think this plays a very important role. People are 
fascinated by automation. We're exploring what this can do for 
medicine, and this has been important in getting people enthused 
about it. The idea of hiring people to do something for you is one 
thing, but the idea of getting a machine that can relieve you of . 
the task and provide you with some information that might have 
to be collected manually otherwise is another kind of thing. Another 
impact of automation or the technology is the business of quality 
control- improving the accuracy of the tests. As you polish a tool 
and make it so that it can measure something more accurately as 
well as more easily, it takes on a different dimension. I'll give you a 
simple example, and that's spirometry. When we started doing 
spirometry, the cost to the patient, based on man hours, was up 
around $25. We can easily do that test now for $2. All of the inter-
pretation can be done, and you can classify the patient as to the 
probability that he is normal or abnormal. We've reduced by a 
factor of at least ten not only the cost procedure but the time it 
takes to do it. 
NoEHREN: There's another side to this coin, you know. We con-
stantly compare the machines with the human interpreter, but as we 
learned from Garland's studies on the reading of X-rays, the human 
interpreters can vary considerably. We assume that the doctor is, 
by definition, correct in his reading of the spirogram and the EKG, 
but if you ask two doctors to read the same EKG, you have a 
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CoLLEN: Yes. There may be an observed variability of 30 to 40 
percent, sometimes. 
NoEHREN: We need ills intuition, but at the same time, he's not in-
fallible. 
CASTLE: There's a considerable variation in the same observer read-
ing an electrocardiogram today as compared to two days from now 
or two years ago. Can you program more reliability into a machine? 
WARNER: That's what we're trying to do- all of us. 
CASTLE: One thing struck me when you said these automated tests 
are being done by people other than physicians. You're taking the 
physician out, but it seems to me it would take highly skilled people. 
Maybe you don't call them doctors, but it would take highly 
trained, advanced people to do the tests you're talking about. 
CoLLEN: That depends, of course, on the test. You do have to match 
the person to the requirements. However, opportunities do develop 
to upgrade people. In taking body measurements, our first technician 
was a graduate who had majored in anthropology. She did very 
well, but after a couple of years she got married and left. We 
couldn't find an adequately trained person to take her place, but 
we had L VN's- nursing aids- and we found they do very well 
because they know the body locations to take measurements. In 
some of the tests, you can train high school graduates to do a 
routine repetitive task over and over, where the task is clearly de-
fined and you can teach them how to do it in a precise manner. 
In other areas, such as the automated chemical analyzers, we have 
a Ph.D. biochemist to supervise that. We have 30 people in the 
laboratory, and that's the range of training- high school to Ph.D. 
CASTLE: Well, what about doing the ocular tension? 
CoLLEN : When we first started, we had physicians doing ocular ten-
sion for glaucoma detection, but in 1964 and 1965 they began to 
train nurses. 
NoEHREN : Who did? 
CoLLEN : The ophthalmologists trained the nurses to do ocular ten-
sion, and since that time they have delegated that routine procedure 
to nurses. We now have nurses who have performed tens of thou-
sands of these examinations, more than many ophthalmologists have 
done, and we have no record of any corneal injury or infection. Our 
ophthalmologists are now satisfied that trained nurses under super-
vision can do ocular tension with the tonometer. 
CASTLE: Do you think if you work at tills long enough and get the 
people well trained that you can get the physician out of it entirely? 
CoLLEN: No. You can get the physician out of individual tasks. We 
can train nurses or corpsmen to detect murmers and do that parti-
I ) 
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cular task. We can train nurses to do pelvics. Everyone knows we 
have very good OB nurses on the OB floors who do the pelvics and 
tell the obstetrician when the baby's ready to come. 
NoEHREN: Have you mentioned tills to your obstetricians lately? 
CoLLEN: We have, but they haven't accepted it yet. We can train 
physicians' assistants to perhaps do sigmoidoscopies. I think we can 
train people to do these individual tasks, but the overall decision-
making process that took us 8 to 12 years to learn cannot be dele-
gated because to train someone to have sufficient experience to do 
that would take 8 to 12 years. Therefore, I think the physician will 
always be the decision-maker. Essentially, he will manage the case. 
He will put it all in the proper context, and make the diagnosis, and 
preScribe treatment tailored to that individual patient by that 
patient's age, sex, education, socio-economic status, occupation, and 
so forth. The M.D. is necessary to make the decisions and prescribe 
and manage the case. All the data acquisition - gathering all the 
information on organs and systems - will be transferred to others 
who can do this task as well, if not better, than the doctor .. 
NoEHREN: How much have you been able to sell tills idea to other 
institutions? It seems to me that acceptance by other groups is a 
critical measure of this whole thing. 
CoLLEN: I don't like to hear you say, "How much have you sold?" 
Because we're not selling it. Others have done a much better job in 
demonstrating the value of, say, pediatric nurse practitioners. There's 
an excellent example in Colorado. 
NoEHREN: I was referring to your basic automated screening pro-
gram. How many other institutions have taken this on for large study 
groups? How about HIP in New York, and the Mayo Clinic, and 
some of those? Have they gone along with this thinking? 
CoLLEN: HIP in New York has applied for and is planning to in-
stitute a program somewhat like ours. 
CASTLE: Maybe these other institutions .don't have the ingredients. 
Dr. Collen, what do you need to launch a program somewhat like 
what you're doing? It seems to me that you need a massive volume 
and almost a captive audience of patients in order to be certain 
that you have the cost benefits you're looking for, and to justify 
the enormous cost of the initial investment. 
CoLLEN : You've covered the requirements, although I don't like to 
use the words "captive patients," because they're not; it's all volun-
tary. Essentially, for a successful multiphasic health-testing program 
one does first need the support of the physicians who take care of 
the patients. The program must be integrated into the continuing 
care of the patient; it cannot function as an island. Secondly, it 
must provide a quality service, which means, as Homer has pointed 
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out, improved quality of testing in a manner acceptable and useful 
to the physicians. Thirdly, it must do it at a cost which is competi-
tive to the usual manner and preferably far below it, and in · order 
to do that and to be able to support automated equipment, one must 
have volume. One m\ll)t do 100 exams or so a day to be able to 
operate with costs such as ours, and this, of course, requires the 
cooperation of the people and the doctors in the community to see 
that adequate numbers go through. Therefore, with the support of 
the physicians and quality service at a reasonable cost, any program 
should succeed. Not everyone has these ingredients, and our history 
has shown that if you don't have all three of these, eventually the 
program will fail. 
CASTLE: You know enough about Salt Lake City to respond as to 
whether or not this community justifies considering such a facility. 
CoLLEN: What's your population? 
CASTLE: Within Salt Lake proper we're talking about 200,000, but 
in the Salt Lake metropolitan area it's 350,000 to 400,000. 
CoLLEN: You have the requirements to provide a very successful 
program. With 200,000 or more, assuming that half of them are 
adults and assuming that one-fourth of them will go through once 
a year, that gives you 25,000 a year, or 2,000 a month. That's 
exactly the volume we have, and that should guarantee you an 
adequate volume for reasonable care. You have a medical center 
with all the expertise, and if your medical society and the physi-
cians in the community will support the program, you have all the 
ingredients for success. 
CASTLE: How can we benefit the more distant communities with 
this facility, though, if we had it in Salt Lake City? How would you 
benefit a population of 10,000 from a community 150 or 200 miles 
from here? Could you take the laboratory there, or would it be bet-
ter to bring the patients here? 
CoLLEN: My opinion is that it is better for the patients to be tran-
sported to the center rather than have the center transported to the 
people. Now, there are several mobile multiphastic screening units 
being evaluted in the country, and others may differ from my 
opinion on this. I think the difficulties of quality standardized tests 
and quality-controlled monitoring is very difficult, and having such 
a multitest laboratory associated with a medical center automati-
cally gives you the necessary quality supervision from the cardiolo-
gist, from the clinical laboratory, from your radiologist, and from all 
the specialists necessary to monitor each of the phases. 
NoEHREN: This is a continuing process, you're saying? 
CoLLEN: To me, quality control is the most difficult, most important 
part of the whole program. Quality control goes on as long as the 
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program goes, and every day, every week, you must continually 
monitor. If you do it the fi.rst year and then say, "We're fine," ~d 
don't do it the second year, it will go downhill. The same quality 
control monitoring that is in your clinical lab can be built in this, 
and your electrocardiogram lab, and your X-ray lab and so forth. 
If you have these mobile units travelling around, who's going to 
monitor their quality control? That's one thing that concerns me. 
WARNER: We have a program now in the Intermountain Area that 
is achieving just this quality control laboratory work. This is run on 
a voluntary basis by the Society of Medical Technologists. Each 
month test sera are sent out to these laboratories, and each day they 
run the test sera through their system. The results are sent to the 
central computer facility, where reports are prepared showing .them 
how each laboratory varies from day to day and how their mean 
differs from the mean of the laboratories. Over a period of several 
years now, these fellows have been able to focus on their prob-
lems if one laboratory systematically differs from another. They then 
examine whether they are doing the test differently, or whether they 
have a different technician, or whatever. With this they have main-
tained a quality control which didn't exist two years ago at all. 
CASTLE: That's just with the clinical laboratories. That certainly 
is good, and should be done, but with the total ~ultitest lab there 
are many other tests that would require some kmd of control. 
NoEHREN: Would you project, Dr. Collen, where this is going in the 
future? Could you give us sort of a Buck Rogers concept of where 
this is all going to end? What is the maximum? What do you dream 
of? 
CoLLEN: To follow on my previous statement, I think that every 
community of 200,000 or more is going to have such an automated 
multitest or multipurpose laboratory. I think that every large med-
ical center in such a community is going to have such a laboratory 
for both inpatient and outpatient in order to be able to provide 
better quality service faster, more accurat~ly, and at less expense. 
I think that each of these centers, then, will be connected to some 
computer center within; perhaps, a hund~ed-mile.radius so that com-
munications costs don t get too expensiVe. ThiS computer center 
will then provide the data base for all these facilities so that patients 
can move among them and the doctors can obtain information from 
them. Furthermore, that computer center will provide the central 
quality control, providing mean values for each of the centers so 
they can compare their lab reports, and so forth. Beyond that, I 
don't know. 
NoEHREN: Will we screen the whole population someday? 
CoLLEN: At certain intervals, although perhaps not yearly. I think 
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ough~ to have an exam. I think people in their 30's ought to be 
exammed at least every three years, those in their 40's every other 
y~ar, those in their 50's maybe every year, those in their 60's every 
nme months, and those in their 70's maybe every six months. 
NoEHREN: Do you really think we're going to come to this? 
CoLLEN: I think we are. 
CASTLE: Do you think we can afford that? 
CoLLEN: With technology and automation, I think we can. 
WARNER: .we have this pretty much now, don't we? I mean the high 
school kids all have to have an exam, and the college kids have an 
exam when they go to college. It's being done by the physician in-
stead of through automated test laboratories. I'd just like to make 
one speculative statement with regard to the long-term effects of this 
kind of endeavor. I look favorably on the sort of thing Dr. Collen 
is doing, and we're struggling with a simple means to an end at 
the moment. It's a means to get a data base, to start getting data 
in a systematic fashion on patients. Ultimately, we'll be able to do 
much more. Dr. Collen is now four years downstream with his pro-
gram, and as he gets five or ten years downstream, he'll be able to 
look back on his data ten years before and see what patterns exist 
in the numbers he gathered on patients which might have told him 
well in advance that these patients ten years later would have deve-
loped this, that, or the other condition. I really think this is the more 
important goal we're all working toward. If periodic examinations 
are not as valuable in the minds of physicians as they might be at 
this point in time, it's simply because we don't yet know how to 
interpret the data. With the help of sophisticated satistical methods 
and with the proper data base for experience, we can accumulate 
information in a form that doctors just can't handle intuitively. We 
already know from certain prototype studies that this is possible, 
and with time we should be able to do a great deal more with the 
information we get than we can now. The startling point has to be 
to get the technology going, to get the data gathered, and we've 
found from experience that the data gathering process is only effec-
tive as long as it provides some service as it goes along. So we're 
all hoping that the service we're providing today is useful enough 
to at least justify its existence. 
CASTLE: Maybe if the doctor isn't interested in doing this and is not 
so concerned about predictive medicine, the patients will be. 
WARNER: I think the doctor is concerned about it. He's frustrated by 
it because we don't really have the facts to know how to do it yet. 
It's only through these systematic data gathering methods that we'll 
eventually get those techniques developed and have the information 
available to make predictions. 
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NoEHREN: It's interesting. He's saying the same thing that Dr. Fein-
stein said about symptoms when he was here. In evaluating the 
symptoms over a period of time, we're going to be able to project 
in the future what this means for disease. Now, these men are telling 
us the same thing for laboratory data - that by developing curves 
and being able to look at the beginning of it, we should be able to 
predict much better. 
CASTLE: Then our findings and symptoms are not different; they 
are just expressed differently. 
NoEHREN: One is subjective and the other is objective. 
CASTLE: One is subjective and the other is more reproducible or 
measurable. 
WARNER: Let me make one other statement about symptoms. I feel 
pretty confident that symptoms will be much less important in the 
future than they are now. Symptoms are a rather late manifestation 
of disordered body processes. There should be many more subtle 
things we can detect through body chemistry, disturbed physiology, 
response to stress, and so on. We know, for instance, that a patient 
who has a congenital heart disease and is limited in his activity may 
really think he feels pretty well, but when he's cured and he has that 
defect repaired, he feels fine. You see, he didn't really know what 
feeling well meant because it sneaks up so gradually. 
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